IonQ Speeds Drug Development Application with AstraZeneca, AWS, and NVIDIA HPCwire
Article Source
https://www.hpcwire.com/off-the-wire/ionq-speeds-quantum-accelerated-drug-development-application-with-astrazeneca-aws-and-nvidia/
Related Posts
Should You Buy Amazon Stock in 2026? | The Motley Fool
The technology giant has underperformed the S&P 500 over the last five years. Did you know that Amazon (AMZN +0.21%)…
How Thomson Reuters built an Agentic Platform Engineering Hub with Amazon Bedrock AgentCore | Amazon Web Services
This post was co-written with Naveen Pollamreddi and Seth Krause from Thomson Reuters. Thomson Reuters (TR) is a leading AI…
Amazon SageMaker AI in 2025, a year in review part 2: Improved observability and enhanced features for SageMaker AI model customization and hosting | Amazon Web Services
In 2025, Amazon SageMaker AI made several improvements designed to help you train, tune, and host generative AI workloads. In…